Bid to buy Glenmark Life for Rs 7000 crore: Nirma leads acquisition race with ChrysCap, Sekhmet Farhat Nasim2 Aug 2023 5:43 PM ISTNew Delhi: Leading the race to acquire Glenmark Life Sciences in a deal that could cost around Rs 7000 crore, Nirma Group has emerged as the...
Washing powder maker Nirma and Sekhmet vie for USD 731 million Glenmark Life stake: Sources Ruchika Sharma17 July 2023 1:30 PM ISTMumbai: Indian conglomerate Nirma Ltd. and PAG-backed Sekhmet Pharmaventures are among the shortlisted bidders for a controlling stake in Glenmark...
PAG-led API Platform concludes acquisition of controlling stake in Optimus Group Ruchika Sharma26 Sept 2022 4:30 PM ISTThe deal follows the acquisition of Anjan Drugs in 2020 by the consortium, which aims to develop a best-in-class center for the development and...
CCI approves acquisition of majority shareholding in Optimus Drugs by Sekhmet Pharmaventures Ruchika Sharma14 Aug 2022 11:00 AM ISTDeals beyond certain thresholds require approval from CCI, which keeps a tab on anti-competitive practices in the market place.
PAG, partners to acquire controlling stake in Optimus Drugs for Rs 2,000 crore Ruchika Sharma15 May 2022 10:00 AM IST''The businesses of the two companies are highly complementary and will provide a solid foundation for the platform to make further acquisitions,'' it...
